Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2019
(1)
2017
(1)
2016
(1)
2010
(1)
Decision
Transfer
(3)
Cancellation, transfer in part
(1)
Complainant
Skechers U.S.A., Inc. II
(1)
Skechers U.S.A., Inc.
(1)
LA CERISE BLEUE
(1)
Facebook Inc.
(1)
F. Hoffmann-La Roche AG
(1)
Respondent
Wuxi Yilian LLC / Wuxi Yilian LLC
(1)
Wang Ming
(1)
W SAS
(1)
Vladimir Kiskov
(1)
Tigran Mosisyan
(1)
Private Person / Kseniya S Dzhabbarova
(1)
Netfirms AB
(1)
Kseniya S Dzhabbarova
(1)
Kseniya Dzhabbarova
(1)
Kravtsov Alexander / Alexander Kravtsov
(1)
MORE
Panelist
Willem J. H. Leppink
(1)
Matthew Kennedy
(1)
Mathias Lilleengen
(1)
Christiane FĂ©ral-Schuhl
(1)
Complainant Country
United States
(2)
Switzerland
(1)
France
(1)
Complainant Representative
Matkowsky Law P.C
(1)
Lovells
(1)
Kleinberg & Lerner, LLP
(1)
Respondent Country
Sweden
(1)
Netherlands
(1)
France
(1)
China
(1)
Respondent Reply
Yes
(2)
No
(2)
RDNH Status
No
(4)
Case Language
English
(3)
French
(1)
Case Particular
DNL
(1)
DLC
(1)
DFR
(1)
D
(1)
Number Of Domains
1
(3)
11
(1)
Domain Extension
xyz
(1)
top
(1)
space
(1)
review
(1)
org
(1)
nu
(1)
nl
(1)
net
(1)
fr
(1)
com.lc
(1)
MORE
Domain Extension Type
ccTLD
(4)
newgTLD
(1)
gTLD
(1)
Domain Length
7
(1)
8
(4)
10
(1)
12
(1)
13
(1)
15
(1)
17
(1)
19
(1)
Includes Hyphen
Yes
(1)
No
(4)
Includes Number
Yes
(1)
No
(4)
Includes Letter
Yes
(4)
Domain Registrar
Gandi SAS
(4)
Todaynic.com, Inc.
(1)
PDR Ltd. d/b/a PublicDomainRegistry.com
(1)
Mesh Digital Limited
(1)
Bizcn.com, Inc.
(1)
1API GmbH
(1)
4
cases found.
Domain Extension Type: ccTLD
Includes Hyphen: No
Includes Number: No
Domain Length: 8
Domain Registrar: Gandi SAS
Reset Search
facebook.com.lc
Transfer
WIPO DLC2019-0001
(Decision Date: Oct. 31, 2019)
skechers.nl
Transfer
WIPO DNL2017-0003
(Decision Date: Feb. 15, 2017)
accutane-online.nu, accutane.space, accutane.top and 8 others...
Cancellation, transfer in part
WIPO D2016-0517
(Decision Date: May 13, 2016)
lacerise.fr
Transfer
WIPO DFR2010-0022
(Decision Date: Sept. 9, 2010)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll